All In MedTech

Device Trial Radar · NCT04797052

EEG Detection of Delirium

Prefrontal EEG Early Detection of Delirium in Older Adults

Last checked: Nov 20, 2026Latest source record: Mar 30, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

234

Actual

Start

Apr 5, 2021

Primary completion

Jan 30, 2023

Study completion Jan 30, 2023

Sponsor

Lead sponsor
Centre hospitalier de l'Université de Montréal (CHUM)Academic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
TransMedTech Institute
First posted
Mar 15, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 65 years, up to 120 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

VEEGix is a portable device developed by NeuroServo for simplifying electroencephalograms at the bedside. It is an easy-to-use device that only requires the operator to place an adhesive strip of electrodes on the patient's forehead, connected to the device. The goal of this study is to determine EEG thresholds for the diagnostic of delirium. Methods : This prospective observational study includes patients undergoing orthopedic or degestive surgery. Each subject will have an EEG reading before surgery and twice daily after surgery until discharge or up to 5 days. Patients will be monitored for post operative delirium using the 3D-Confusion Assessment Method. Delirium diagnostic will be confirmed by a geriatrician. EEG relative power reading will be compared between patient with and without a delirium diagnostic.

Conditions

  • Post Operative Delirium

Interventions

  • Prefrontal EEG (VEEGix by NeuroServo)Device

    Prefrontal EEG reading

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Difference of relative power of delta and theta brain wavesTime frame: up to five days after the operation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Centre Hospitalier de l'Université de Montréal

    Montreal, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.